Nvidia CEO says next chip for China won't be from Hopper series, Reuters says
Nvidia (NVDA) is evaluating how to address the China market after the U.S. government placed limits on sales of its Hopper H20 chip, but notes they will not put out another version from the Hopper series, Wen-Yee Lee of Reuters reports, citing comments made by CEO Jensen Huang. When asked what their next chip for China after the H20 was, Huang said, 'It's not Hopper because it's not possible to modify Hopper anymore.'
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Pause in ECB rate cuts could last a while, policymaker Holzmann tells Austrian TV
VIENNA (Reuters) -The current pause in European Central Bank rate cuts could be long-lasting unless economic data worsens, in which case there could be further rate cuts this year, policymaker Robert Holzmann told Austrian broadcaster ORF on Monday. "It could be that the pause lasts a while," he said when asked if there would be further rate cuts this year, adding each rate decision was based on the data available at that time. "If economic developments worsen, there could be further interest-rate cuts." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
39 minutes ago
- Yahoo
Why Universal Health Services (UHS) Shares Are Trading Lower Today
Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.7% in the afternoon session after Chief Financial Officer Steve Filton noted during a recent conference that procedural volumes (an important driver of hospital revenue) "have been slower to recover back to historical levels than we might have imagined." Filton also voiced concern over the Trump administration's proposed federal spending bill, particularly its implications for healthcare funding. Since UHS derives a significant portion of its revenue from government programs like Medicare and Medicaid, the anticipated cuts to Medicaid could significantly affect the company, especially in regions with high dependency on public healthcare funding. The shares closed the day at $177.76, down 6.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Universal Health Services? Access our full analysis report here, it's free. Universal Health Services's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 28 days ago when the stock gained 5.9% after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Universal Health Services is down 1.1% since the beginning of the year, and at $177.77 per share, it is trading 26.4% below its 52-week high of $241.52 from September 2024. Investors who bought $1,000 worth of Universal Health Services's shares 5 years ago would now be looking at an investment worth $1,628. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
OpenAI's annualized revenue hits $10 billion, up from $5.5 billion in December 2024
(Reuters) -OpenAI ( said on Monday that its annualized revenue run rate surged to $10 billion as of June, positioning the company to hit its full-year target amid booming AI adoption. Its projected annual revenue figure based on current revenue data, which was about $5.5 billion in December 2024, has demonstrated strong growth as the adoption and use of its popular ChatGPT artificial-intelligence models continue to rise. This means OpenAI is on track to achieve its revenue target of $12.7 billion in 2025, which it had shared with investors earlier. The $10 billion figure excludes licensing revenue from OpenAI-backer Microsoft and large one-time deals, an OpenAI spokesperson confirmed. The details were first reported by CNBC. Considering the startup lost about $5 billion last year, OpenAI's revenue milestone shows how far ahead the company is in revenue scale compared to its competitors, which are also benefiting from growing AI adoption. Anthropic recently crossed $3 billion in annualized revenue on booming demand from code-gen startups using its models. OpenAI said in March it would raise up to $40 billion in a new funding round led by SoftBank Group, at a $300 billion valuation. In more than two years since it rolled out its ChatGPT chatbot, the company has introduced a bevy of subscription offerings for consumers as well as businesses. OpenAI had 500 million weekly active users as of the end of this March.
